170 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
29 Apr 24
Enlivex CEO Issues Letter to Shareholders – Perspectives on Recent Events
8:01am
such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
22 Apr 24
Report of Foreign Private Issuer
8:02am
to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that forward-looking statements involve
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
16 Apr 24
Report of Foreign Private Issuer
8:00am
such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned
6-K
EX-99.1
8j44351jlxoftnl09mtx
11 Apr 24
Enlivex Announces Topline Results of Its Phase II Trial Evaluating Allocetra™ In Patients With Sepsis
8:13am
6-K
EX-99.1
t9x24gv
29 Mar 24
Report of Foreign Private Issuer
4:30pm
6-K
EX-99.1
xy2ruu
7 Feb 24
Enlivex Announces Issuance of New U.S. Patent Covering Allocetra Cells and Their Manufacturing Method
8:02am
6-K
axdkzu wpm6nc
22 Jan 24
Report of Foreign Private Issuer
8:00am
6-K
EX-99.1
jm7rkgzuzhdeotzm66
17 Jan 24
Report of Foreign Private Issuer
8:02am
6-K
EX-99.1
87grz5j18p 3me
20 Dec 23
Enlivex Announces Completion of Enrollment of Its Phase II Trial Evaluating Allocetra In Patients With Sepsis
8:01am
6-K
EX-99.2
a95ku
9 Nov 23
Condensed Consolidated Financial Statements
4:30pm
6-K
iik1d d3qzpk
7 Nov 23
Report of Foreign Private Issuer
4:30pm
6-K
3uauwev6
18 Sep 23
Report of Foreign Private Issuer
8:00am
6-K
EX-99.1
bb7wccd
11 Sep 23
Enlivex Announces Reprioritization Plan and Second Quarter 2023 Financial Results
8:00am
6-K
EX-99.2
ptevxmc
1 Sep 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
mg4p3n p9sqr
2 Aug 23
Report of Foreign Private Issuer
8:05am
6-K
EX-99.1
y5o97vwik ypc3u
31 Jul 23
Enlivex Announces Dosing of First Patient Under The Amended Protocol Of Its Phase II trial Evaluating Allocetra™ In Patients With Sepsis
8:05am
6-K
EX-99.1
y8v qx35oq
26 Jun 23
Enlivex Announces First Quarter 2023 Financial Results and Provides a Business Update
8:03am
6-K
EX-99.2
p4c6c kdwyw
16 Jun 23
Condensed Consolidated Financial Statements
4:30pm